{"id":"https://openalex.org/W2015123282","doi":"https://doi.org/10.1007/s002109900170","title":"A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo","display_name":"A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo","publication_year":2000,"publication_date":"2000-02-01","ids":{"openalex":"https://openalex.org/W2015123282","doi":"https://doi.org/10.1007/s002109900170","mag":"2015123282","pmid":"https://pubmed.ncbi.nlm.nih.gov/10685875"},"language":"en","primary_location":{"id":"doi:10.1007/s002109900170","doi":"https://doi.org/10.1007/s002109900170","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002109900170","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012430714","display_name":"Helen L. Rowley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H.L. Rowley","raw_affiliation_strings":["Biology, BASF Pharma Research and Development, Nottingham, UK. Helen.Rowley@basf-pharma.co.uk","Biology, BASF Pharma Research and Development, Pennyfoot Street, Nottingham NG1 1GF, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biology, BASF Pharma Research and Development, Nottingham, UK. Helen.Rowley@basf-pharma.co.uk","institution_ids":[]},{"raw_affiliation_string":"Biology, BASF Pharma Research and Development, Pennyfoot Street, Nottingham NG1 1GF, UK,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019492655","display_name":"Patricia L. Needham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P.L. Needham","raw_affiliation_strings":["Biology, BASF Pharma Research and Development, Pennyfoot Street, Nottingham NG1 1GF, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biology, BASF Pharma Research and Development, Pennyfoot Street, Nottingham NG1 1GF, UK,","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000907908","display_name":"Ian C. Kilpatrick","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I.C. Kilpatrick","raw_affiliation_strings":["Biology, BASF Pharma Research and Development, Pennyfoot Street, Nottingham NG1 1GF, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biology, BASF Pharma Research and Development, Pennyfoot Street, Nottingham NG1 1GF, UK,","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037798281","display_name":"David J. Heal","orcid":"https://orcid.org/0000-0002-6128-9632","observed_orcids":["https://orcid.org/0000-0002-6128-9632"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D.J. Heal","raw_affiliation_strings":["Biology, BASF Pharma Research and Development, Pennyfoot Street, Nottingham NG1 1GF, UK,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biology, BASF Pharma Research and Development, Pennyfoot Street, Nottingham NG1 1GF, UK,","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":1.2606,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.79063028,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"361","issue":"2","first_page":"187","last_page":"192"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6518999934196472,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6518999934196472,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.3402999937534332,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zotepine","display_name":"zotepine","score":1.0},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8289999961853027},{"id":"https://openalex.org/keywords/extracellular-dopamine","display_name":"extracellular dopamine","score":0.8029999732971191},{"id":"https://openalex.org/keywords/frontal-cortex","display_name":"frontal cortex","score":0.8539999723434448},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.9179999828338623},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":1.0},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":1.0},{"id":"https://openalex.org/keywords/nisoxetine","display_name":"nisoxetine","score":0.8460000157356262},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8190000057220459},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7609999775886536},{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.8679999709129333},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.6759999990463257},{"id":"https://openalex.org/keywords/dopamine-release","display_name":"dopamine release","score":0.3889999985694885}],"concepts":[{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.7916252613067627},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.6862986087799072},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.6690648198127747},{"id":"https://openalex.org/C50156730","wikidata":"https://www.wikidata.org/wiki/Q3856966","display_name":"Microdialysis","level":3,"score":0.6164578795433044},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5742805004119873},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4672197103500366},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4638860821723938},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4330289661884308},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.43267592787742615},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4101092219352722},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3783853054046631},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3304321765899658},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3262982964515686},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.15215876698493958},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003988","descriptor_name":"Dibenzothiepins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005473","descriptor_name":"Fluoxetine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005625","descriptor_name":"Frontal Lobe","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D005625","descriptor_name":"Frontal Lobe","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010890","descriptor_name":"Pirenzepine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011954","descriptor_name":"Receptors, Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011985","descriptor_name":"Receptors, Serotonin","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017551","descriptor_name":"Microdialysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s002109900170","doi":"https://doi.org/10.1007/s002109900170","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002109900170","pdf_url":null,"source":{"id":"https://openalex.org/S159534381","display_name":"Naunyn-Schmiedeberg s Archives of Pharmacology","issn_l":"0028-1298","issn":["0028-1298","0340-5249","1432-1912"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's Archives of Pharmacology","raw_type":"journal-article"},{"id":"pmid:10685875","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10685875","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Naunyn-Schmiedeberg's archives of pharmacology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320312","display_name":"Home Office","ror":"https://ror.org/00y81cg83"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W122505910","https://openalex.org/W1662574854","https://openalex.org/W1885238897","https://openalex.org/W1965822729","https://openalex.org/W1966092598","https://openalex.org/W1971280977","https://openalex.org/W1972803223","https://openalex.org/W1980773450","https://openalex.org/W1986420342","https://openalex.org/W1994999112","https://openalex.org/W1996657079","https://openalex.org/W2010221886","https://openalex.org/W2022765281","https://openalex.org/W2023734494","https://openalex.org/W2029746418","https://openalex.org/W2030580293","https://openalex.org/W2030758738","https://openalex.org/W2039534965","https://openalex.org/W2043393596","https://openalex.org/W2044907318","https://openalex.org/W2050121560","https://openalex.org/W2054231808","https://openalex.org/W2055686502","https://openalex.org/W2058840813","https://openalex.org/W2059620249","https://openalex.org/W2062451323","https://openalex.org/W2068026066","https://openalex.org/W2074385687","https://openalex.org/W2075027779","https://openalex.org/W2075433027","https://openalex.org/W2083252023","https://openalex.org/W2085360366","https://openalex.org/W2093353397","https://openalex.org/W2099935324","https://openalex.org/W2120063529","https://openalex.org/W2133510276","https://openalex.org/W2151331628","https://openalex.org/W2163015549","https://openalex.org/W2163815564","https://openalex.org/W2264009361","https://openalex.org/W2395710532","https://openalex.org/W2412622445","https://openalex.org/W2413293679","https://openalex.org/W2415246766","https://openalex.org/W2461457834"],"related_works":["https://openalex.org/W2058840813","https://openalex.org/W2068026066","https://openalex.org/W1946515464","https://openalex.org/W2092895227","https://openalex.org/W1972522199","https://openalex.org/W1972803223","https://openalex.org/W2091932588","https://openalex.org/W2104465880","https://openalex.org/W1629129452","https://openalex.org/W1493395004"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}